LD-2 disclosure · 2nd Quarter - Report
INVITAE INC.
Client
- Name
- INVITAE INC.
- Description
- Company that provides clinical genetic testing services.
- Location
- California · United States of America
Registrant
- Description
- Government Affairs Consulting firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
5 issuesMedical/Disease Research/Clinical Labs
H.R.2369 - VALID Act of 2023 FDA Guidance, Docket No. FDA-2022-D-2983 for Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products FDA public meeting, FDA-2018-N-4002 Electronic Submission of Adverse Event Reports to FAERS Using ICH E2B(R3) Standards FDA guidance, Docket No. FDA-2023-D-0110: Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics
LobbyistsJENNIFER RACHEL LEIB · MEGAN ANDERSON BROOKS · LINDSEY TRISCHLER
Covered position (JENNIFER RACHEL LEIB): Fellow, Senate Committee on Health, Education, Labor, and Pensions
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Medicare/Medicaid
No bill #: Precision Medicine Access for Kids Today Act
LobbyistsJENNIFER RACHEL LEIB · MEGAN ANDERSON BROOKS · LINDSEY TRISCHLER
Covered position (JENNIFER RACHEL LEIB): Fellow, Senate Committee on Health, Education, Labor, and Pensions
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
S.2140: Patent Eligibility Restoration Act